KRChoksey`s research report on Cadila Healthcare Cadila Healthcare, net sales grew by 25.7% YoY to Rs2020crs driven by improved traction in US business & Emerging markets. EBIDTA excluding forex impact grew by 42.3% YoY to Rs371crs & EBITDA ... Moneycontrol.com, 2 weeks ago
Hold Cadila Healthcare; target of Rs 1300: Sharekhan - Moneycontrol.com, 3 weeks ago
Accumulate Cadila Healthcare; tgt of Rs 1309: Dolat Capital - Moneycontrol.com, 3 weeks ago
1 images for "cadila healthcare click"
Cadila Healthcare Ltd has submitted to BSE a copy of proceedings of the 19th Annual General Meeting of the members of the Company held on July 30, 2014.Source : BSE Read all announcements in Cadila Health To read the full reportMoneycontrol.com, 2 weeks ago Cadila Healthcare's AGM on July 30, 2014 Moneycontrol.com, 1 month ago
The page you are looking for might have been removed, had its name changed, or is temporarily unavailable. Please try the following: Make sure that the Web site address displayed in the address bar of your browser is spelled and formatted ...SBICAP Securities, 1 week ago Zydus receives final approval for Acyclovir Tablets Moneycontrol.com, 1 week ago Zydus receives final approval for Potassium Citrate ER Tablets Moneycontrol.com, 3 weeks ago
The page you are looking for might have been removed, had its name changed, or is temporarily unavailable. Please try the following: Make sure that the Web site address displayed in the address bar of your browser is spelled and formatted ...SBICAP Securities, 4 weeks ago Cadila Healthcare to declare Q1 financial results on July 30 SBICAP Securities, 1 month ago Cadila Healthcar - Cut-off Date for E-Voting SBICAP Securities, 1 month ago
Motilal Oswal has come out with its report on healthcare sector. Among MNCs, Sanofi India is likely to be the most impacted, while Indian companies are expected to see a PAT impact of 1-4%, says report. New directive expands span of price control ...Moneycontrol.com, 1 month ago
Sharekhan: Q1FY2015 pharma earnings preview We expect the strong growth seen in the pharma sector in the previous quarter to continue in Q1FY2015 on the back of a robust performance of the pharma companies in the US market. On an aggregate basis, ...Moneycontrol.com, 1 month ago Sharekhan positive on pharma; prefers Aurobindo, Torrent Moneycontrol.com, 1 month ago
] Biocon Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, ' Biocon Limited - Product Pipeline Review - 2014', provides an overview of the Biocon Limited's pharmaceutical research and development focus. This report ...4 Traders, 2 days ago
* BSE index falls 0.74 pct; NSE ends 0.9 pct lower * ICICI Bank falls; adjusted profit below estimates * IRB Infra shares surge on toll income growth By Abhishek Vishnoi MUMBAI, July 31 (Reuters) - India's broader NSE index fellnearly 1 percent on Thursday, ...Sify, 4 weeks ago Sensex falls most in 2-1/2 weeks; earnings fail to impress Sify, 4 weeks ago
TV18 Broadcast, Tata Motors and ONGC were the top buys, while Gammon Infrastructure, Triveni Engineering and Jaypee Infratech were the top sells by the fund. The study of State Bank of India Mutual Fund for the quarter of April-June 2014 shows that ...Moneycontrol.com, 1 month ago
Shares of pharmaceutical companies selling cardiac and diabetes drugs in India saw deep cuts on Monday, with MNC drug maker Sanofi India losing more than 10% after the Indian drug pricing authority capped the price at which these companies sell ...Financial Express, 1 month ago
on your WebpageAdd Widget >Get your members hooked!